Cargando…

S2k guideline on diagnosis and treatment of atopic dermatitis — short version

Atopic dermatitis (AD) represents a pruritic, non-contagious, chronic or chronically relapsing, inflammatory skin disease. The course of the disease may be complicated by bacterial or viral superinfections. The first manifestation of the disease and further flare-ups are due to genetic predispositio...

Descripción completa

Detalles Bibliográficos
Autores principales: Werfel, Thomas, Heratizadeh, Annice, Aberer, Werner, Ahrens, Frank, Augustin, Matthias, Biedermann, Tilo, Diepgen, Thomas, Fölster-Holst, Regina, Gieler, Uwe, Kahle, Julia, Kapp, Alexander, Nast, Alexander, Nemat, Katja, Ott, Hagen, Przybilla, Bernhard, Roecken, Martin, Schlaeger, Martin, Schmid-Grendelmeier, Peter, Schmitt, Jochen, Schwennesen, Thomas, Staab, Doris, Worm, Margitta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861742/
https://www.ncbi.nlm.nih.gov/pubmed/27239428
http://dx.doi.org/10.1007/s40629-016-0110-8
_version_ 1782431246535622656
author Werfel, Thomas
Heratizadeh, Annice
Aberer, Werner
Ahrens, Frank
Augustin, Matthias
Biedermann, Tilo
Diepgen, Thomas
Fölster-Holst, Regina
Gieler, Uwe
Kahle, Julia
Kapp, Alexander
Nast, Alexander
Nemat, Katja
Ott, Hagen
Przybilla, Bernhard
Roecken, Martin
Schlaeger, Martin
Schmid-Grendelmeier, Peter
Schmitt, Jochen
Schwennesen, Thomas
Staab, Doris
Worm, Margitta
author_facet Werfel, Thomas
Heratizadeh, Annice
Aberer, Werner
Ahrens, Frank
Augustin, Matthias
Biedermann, Tilo
Diepgen, Thomas
Fölster-Holst, Regina
Gieler, Uwe
Kahle, Julia
Kapp, Alexander
Nast, Alexander
Nemat, Katja
Ott, Hagen
Przybilla, Bernhard
Roecken, Martin
Schlaeger, Martin
Schmid-Grendelmeier, Peter
Schmitt, Jochen
Schwennesen, Thomas
Staab, Doris
Worm, Margitta
author_sort Werfel, Thomas
collection PubMed
description Atopic dermatitis (AD) represents a pruritic, non-contagious, chronic or chronically relapsing, inflammatory skin disease. The course of the disease may be complicated by bacterial or viral superinfections. The first manifestation of the disease and further flare-ups are due to genetic predisposition and also to a variety of further trigger factors. The therapy regimen should be adapted to disease symptoms that are actually present and consider individual features of the disease as reported by the patients or their parents. This short version of the German guideline on AD provides an overview of evidence-based diagnostic and treatment options. All recommendations made here are the result of a consensus of the scientific medical societies, working groups and support groups based on scientific data published to date. Abstracts and details of the studies cited are provided in the long version of this guideline (see: www.awmf.org).
format Online
Article
Text
id pubmed-4861742
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-48617422016-05-25 S2k guideline on diagnosis and treatment of atopic dermatitis — short version Werfel, Thomas Heratizadeh, Annice Aberer, Werner Ahrens, Frank Augustin, Matthias Biedermann, Tilo Diepgen, Thomas Fölster-Holst, Regina Gieler, Uwe Kahle, Julia Kapp, Alexander Nast, Alexander Nemat, Katja Ott, Hagen Przybilla, Bernhard Roecken, Martin Schlaeger, Martin Schmid-Grendelmeier, Peter Schmitt, Jochen Schwennesen, Thomas Staab, Doris Worm, Margitta Allergo J Int Review Atopic dermatitis (AD) represents a pruritic, non-contagious, chronic or chronically relapsing, inflammatory skin disease. The course of the disease may be complicated by bacterial or viral superinfections. The first manifestation of the disease and further flare-ups are due to genetic predisposition and also to a variety of further trigger factors. The therapy regimen should be adapted to disease symptoms that are actually present and consider individual features of the disease as reported by the patients or their parents. This short version of the German guideline on AD provides an overview of evidence-based diagnostic and treatment options. All recommendations made here are the result of a consensus of the scientific medical societies, working groups and support groups based on scientific data published to date. Abstracts and details of the studies cited are provided in the long version of this guideline (see: www.awmf.org). Springer Medizin 2016-05-02 2016 /pmc/articles/PMC4861742/ /pubmed/27239428 http://dx.doi.org/10.1007/s40629-016-0110-8 Text en © Springer Medizin 2016
spellingShingle Review
Werfel, Thomas
Heratizadeh, Annice
Aberer, Werner
Ahrens, Frank
Augustin, Matthias
Biedermann, Tilo
Diepgen, Thomas
Fölster-Holst, Regina
Gieler, Uwe
Kahle, Julia
Kapp, Alexander
Nast, Alexander
Nemat, Katja
Ott, Hagen
Przybilla, Bernhard
Roecken, Martin
Schlaeger, Martin
Schmid-Grendelmeier, Peter
Schmitt, Jochen
Schwennesen, Thomas
Staab, Doris
Worm, Margitta
S2k guideline on diagnosis and treatment of atopic dermatitis — short version
title S2k guideline on diagnosis and treatment of atopic dermatitis — short version
title_full S2k guideline on diagnosis and treatment of atopic dermatitis — short version
title_fullStr S2k guideline on diagnosis and treatment of atopic dermatitis — short version
title_full_unstemmed S2k guideline on diagnosis and treatment of atopic dermatitis — short version
title_short S2k guideline on diagnosis and treatment of atopic dermatitis — short version
title_sort s2k guideline on diagnosis and treatment of atopic dermatitis — short version
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861742/
https://www.ncbi.nlm.nih.gov/pubmed/27239428
http://dx.doi.org/10.1007/s40629-016-0110-8
work_keys_str_mv AT werfelthomas s2kguidelineondiagnosisandtreatmentofatopicdermatitisshortversion
AT heratizadehannice s2kguidelineondiagnosisandtreatmentofatopicdermatitisshortversion
AT abererwerner s2kguidelineondiagnosisandtreatmentofatopicdermatitisshortversion
AT ahrensfrank s2kguidelineondiagnosisandtreatmentofatopicdermatitisshortversion
AT augustinmatthias s2kguidelineondiagnosisandtreatmentofatopicdermatitisshortversion
AT biedermanntilo s2kguidelineondiagnosisandtreatmentofatopicdermatitisshortversion
AT diepgenthomas s2kguidelineondiagnosisandtreatmentofatopicdermatitisshortversion
AT folsterholstregina s2kguidelineondiagnosisandtreatmentofatopicdermatitisshortversion
AT gieleruwe s2kguidelineondiagnosisandtreatmentofatopicdermatitisshortversion
AT kahlejulia s2kguidelineondiagnosisandtreatmentofatopicdermatitisshortversion
AT kappalexander s2kguidelineondiagnosisandtreatmentofatopicdermatitisshortversion
AT nastalexander s2kguidelineondiagnosisandtreatmentofatopicdermatitisshortversion
AT nematkatja s2kguidelineondiagnosisandtreatmentofatopicdermatitisshortversion
AT otthagen s2kguidelineondiagnosisandtreatmentofatopicdermatitisshortversion
AT przybillabernhard s2kguidelineondiagnosisandtreatmentofatopicdermatitisshortversion
AT roeckenmartin s2kguidelineondiagnosisandtreatmentofatopicdermatitisshortversion
AT schlaegermartin s2kguidelineondiagnosisandtreatmentofatopicdermatitisshortversion
AT schmidgrendelmeierpeter s2kguidelineondiagnosisandtreatmentofatopicdermatitisshortversion
AT schmittjochen s2kguidelineondiagnosisandtreatmentofatopicdermatitisshortversion
AT schwennesenthomas s2kguidelineondiagnosisandtreatmentofatopicdermatitisshortversion
AT staabdoris s2kguidelineondiagnosisandtreatmentofatopicdermatitisshortversion
AT wormmargitta s2kguidelineondiagnosisandtreatmentofatopicdermatitisshortversion